ChemBK
  • Home
  • Product Category
  • CHN
  1. Home
  2. CAS 1262414-04-9
  3. Supplier List
  4. MedChemExpress (MCE)
  5. Signaling Pathways
  6. ACT-334441

Request for quotation








Supplier Contact

Supplier NameMedChemExpress (MCE)
Contactsales
Tel609-228-6898
Mobile609-228-6898
QQ
Emailsales@medchemexpress.com; tech@medchemexpress.com
Websitehttps://www.medchemexpress.com/
Wechat
Product NameAbediterol
SynonymsCS-2487
CENERIMOD
Abediterol
ACT-334441
CENERIMOD
ACT334441
ACT 334441

Synonyms

CS-2487
CENERIMOD
Abediterol
ACT-334441
CENERIMOD
ACT334441
ACT 334441
(S)-3-(4-(5-(2-CYCLOPENTYL-6-METHOXYPYRIDIN-4-YL)-1,2,4-OXADIAZOL-3-YL)-2-ETHYL-6-METHYLPHENOXY)PROPANE-1,2-DIOL
1,2-Propanediol, 3-[4-[5-(2-cyclopentyl-6-methoxy-4-pyridinyl)-1,2,4-oxadiazol-3-yl]-2-ethyl-6-methylphenoxy]-, (2S)-
CAS1262414-04-9
EINECS
Chemical FormulaC25H31N3O5
Molecular Weight453.53
inchi
Package10 mM * 1 mL;1 mg;5 mg;10 mg;25 mg;50 mg
PriceEmail to quote
DescriptionsCenerimod

Cenerimod

MedChemExpress (MCE)

HY-17606

1262414-04-9

ACT-334441

99.43%

Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month

Room temperature in continental US

Descriptions

Cenerimod

Cenerimod

MedChemExpress (MCE)

HY-17606

1262414-04-9

ACT-334441

99.43%

Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month

Room temperature in continental US
may vary elsewhere.

Cenerimod (ACT-334441) is a potent, selective and orally active S1P1 receptor modulator, with an EC50 of 1 nM. Cenerimod shows more than 36 fold selctivity for hS1P1 over hS1P2, hS1P3, hS1P4, and hS1P5 receptor subtypes (EC50s=>10000, 228, 2134, and 36 nM, respectively). Cenerimod can attenuate murine experimental autoimmune encephalomyelitis (EAE) and murine sclerodermatous.

Cenerimod is a highly potent S1P1 receptor agonists in (35S)-GTPγS assays using HUVEC cell membrane preparations, with an EC50 of 2 nM[1]. Cenerimod activates G protein and increases Ca2+ signaling in CHO cells, with EC50s of 1 nM and 124 nM, respectively[1]. Cenerimod (5 μM
24 h) inhibits collagen production in fibroblasts[2].

Cenerimod (0.1-10 mg/kg
a single p.o.) reversibly reduces the number of circulating lymphocytes in a dose-dependent manner in rats[1]. Cenerimod (6 mg/kg/day for 30 days
p.o.) attenuates disease in a mouse experimental autoimmune encephalitis (EAE) model[1]. Cenerimod (10 mg/kg/day for 42 days
p.o.) attenuates skin and lung fibrosis in Scl-cGVHD mice[2].

S1PR1 1 nM (EC50) S1PR5 36 nM (EC50) S1PR5 228 nM (EC50) S1PR4 2134 nM (EC50)

| | | |

| | | | | |



[1]. Piali L, et, al. Cenerimod, a novel selective S1P 1 receptor modulator with unique signaling properties. Pharmacol Res Perspect. 2017 Dec
5(6):e00370.
[Content Brief]

[2]. Kano M, et, al. Attenuation of murine sclerodermatous models by the selective S1P 1 receptor modulator cenerimod. Sci Rep. 2019 Jan 24
9(1):658.
[Content Brief]

Supplier Websitehttps://www.medchemexpress.com/Cenerimod.html
Last Update2025-05-21 16:50:25
MedChemExpress (MCE) also provides

Thalidomide-4-O-C2-NH2

Category: Signaling Pathways
CAS: 2341840-99-9
Last Update: 2025-05-21 16:50:25

PPARα-MO-1

Category: Signaling Pathways
CAS: 810677-36-2
Last Update: 2025-05-21 16:50:25

Netupitant N-oxide

Category: Signaling Pathways
CAS: 910808-11-6
Last Update: 2025-05-21 16:50:25

MK-0812

Category: Signaling Pathways
CAS: 624733-88-6
Last Update: 2025-05-21 16:50:25

TS-011

Category: Signaling Pathways
CAS: 339071-18-0
Last Update: 2025-05-21 16:50:25

SCH 530348 sulfate

Category: Signaling Pathways
CAS: 705260-08-8
Last Update: 2025-05-21 16:50:25

BAG 956

Category: Signaling Pathways
CAS: 853910-02-8
Last Update: 2025-05-21 16:50:25

YM758

Category: Signaling Pathways
CAS: 312752-85-5
Last Update: 2025-05-21 16:50:25
  • Home
  • Product Category

© 2015 ChemBK.com All Rights Reserved | Build: 20150530002